The Registration on the Use of Feilike Heji in Minors

NCT ID: NCT04658992

Last Updated: 2021-08-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-12-15

Study Completion Date

2022-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Feilike HeJi is produced by Guizhou Jianxing Pharmaceutical Co. LTD. For the treatment of phlegm heat caused by lung cough phlegm yellow, bronchial asthma, bronchitis, see the syndrome of proprietary Chinese medicine (approval number: Z20025136) approved by the state and the drug from radix scutellariae, radix peucedani, radix stemonae, red gentian root of deal, phoenix tree, spreading hedyotis herb, red tube 7 flavour, with qingrejiedu, antitussive expectorant effect. In order to fully understand the safety of Feilike HeJi in clinical practice and fulfill the responsibility of production enterprises for patients, the production enterprises initiated this study to further evaluate the safety and understanding of the function characteristics of Feilike HeJi in a wide range of people, so as to guide the clinical rational drug use.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bronchial Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All minor patients (age \<18 years old) who use Feilike Mixture at the specified monitoring time and in the monitoring center (department) .
* Voluntarily participate in this study and meet ethical requirements.

Exclusion Criteria

* Not Applicable.
Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

China Academy of Chinese Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zhong Wang

researcher

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jing Liu, Prof

Role: STUDY_DIRECTOR

Beijing Children's Hospital affiliated to Capital Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beijing Children's Hospital affiliated to Capital Medical University

Beijing, Beijing Municipality, China

Site Status RECRUITING

Beijing Pinggu Hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Beijing Changping Hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Peking University Binhai Hospital

Beijing, Beijing Municipality, China

Site Status NOT_YET_RECRUITING

The Third Affiliated Hospital, Sun Yat-sen University

Guangzhou, Guangdong, China

Site Status NOT_YET_RECRUITING

The Second People's Hospital of Huadu District, Guangzhou

Guangzhou, Guangdong, China

Site Status NOT_YET_RECRUITING

Shenzhen Pingshan Women's and Children's Health Hospital

Shenzhen, Guangdong, China

Site Status NOT_YET_RECRUITING

The First People's Hospital of Bijie City

Bijie, Guizhou, China

Site Status NOT_YET_RECRUITING

Guiyang Maternal and Child Health Hospital

Guiyang, Guizhou, China

Site Status NOT_YET_RECRUITING

Harbin Children's Hospital

Haerbin, Helongjiang, China

Site Status NOT_YET_RECRUITING

Changsha First Hospital

Changsha, Hunan, China

Site Status NOT_YET_RECRUITING

Xiangya San Hospital, Central South University

Changsha, Hunan, China

Site Status NOT_YET_RECRUITING

You County People's Hospital

Zhuzhou, Hunan, China

Site Status RECRUITING

Second Affiliated Clinic, Nanjing Medical University

Nanjing, Jiangsu, China

Site Status RECRUITING

Jiangxi Children's Hospital

Nanchang, Jiangxi, China

Site Status RECRUITING

Lotus County Maternal and Child Health Hospital

Pingxiang, Jiangxi, China

Site Status RECRUITING

Haicheng Central Hospital

Anshan, Liaoning, China

Site Status RECRUITING

Fengcheng Central Hospital

Fengcheng, Liaoning, China

Site Status RECRUITING

The First Hospital affiliated with The Chinese Medical University

Shenyang, Liaoning, China

Site Status RECRUITING

Qilu Hospital

Jinan, Shandong, China

Site Status NOT_YET_RECRUITING

The First Affiliated Hospital of Air Force Military Medical University

Xian, Shanxi, China

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jing Liu, Prof

Role: CONTACT

010-59616885

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jing Liu, Prof.

Role: primary

010-59616885

Xiuying Mao, Bachelor

Role: primary

13716295500

Ting Zhou, Bachelor

Role: primary

13521345341

Ling Yao, Bachelor

Role: primary

13516118161

Zhuanggui Chen, Doctor

Role: primary

13600009221

Hong Zhou, Bachelor

Role: primary

13926295809

Hanhua Yang, Doctor

Role: primary

13537784919

XInqian Zhao, Bachelor

Role: primary

18076153333

Fei Wang, Bachelor

Role: primary

18985016299

Yanqiu Zhang, Bachelor

Role: primary

13654649272

XIangyun Wang, Bachelor

Role: primary

13973123613

Zuocheng Yang, Doctor

Role: primary

13787170289

Xirong Fu, Bachelor

Role: primary

13397536825

Jing Gong, Doctor

Role: primary

13705189604

Lan Li, Master

Role: primary

13077913093

Zhihao Liu, Bachelor

Role: primary

15279903368

Na Yin, Bachelor

Role: primary

1394255631

Hong Jiang, Master

Role: primary

13940195519

Xin Sun, Doctor

Role: primary

13572536262

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Feilike V2.0

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effectiveness of Chinese Herbal Therapy for Asthma
NCT00712296 TERMINATED PHASE1/PHASE2